期刊文献+

治疗便秘型肠易激综合征新药linaclotide

下载PDF
导出
摘要 便秘型肠易激综合征(IBS-C)是一种胃肠功能紊乱疾病,伴有周期性便秘与较频繁的正常大便交替,大便经常有白色黏液,疼痛呈绞榨样,阵发性发作,或持续性隐痛,排便后可缓解。进食常会促发症状,也可以出现腹胀、恶心、消化不良和烧心等症状。IBS-C是一个全球性的问题,
作者 肖辉
出处 《药物流行病学杂志》 CAS 2013年第12期681-683,共3页 Chinese Journal of Pharmacoepidemiology
  • 相关文献

参考文献11

  • 1E. M. M. Quigley,J. Tack,W. D. Chey,S. S. Rao,J. Fortea,M. Falques,C. Diaz,S. J. Shiff,M. G. Currie,J. M. Johnston.Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints[J].Aliment Pharmacol Ther.2012(1)
  • 2Jeffrey M. Johnston,Caroline B. Kurtz,James E. MacDougall,Bernard J. Lavins,Mark G. Currie,Donald A. Fitch,Chris O’Dea,Mollie Baird,Anthony J. Lembo.Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation[J].Gastroenterology.2010(6)
  • 3Robert W. Busby,Alexander P. Bryant,Wilmin P. Bartolini,Etchell A. Cordero,Gerhard Hannig,Marco M. Kessler,Shalina Mahajan-Miklos,Christine M. Pierce,Robert M. Solinga,Li Jing Sun,Jenny V. Tobin,Caroline B. Kurtz,Mark G. Currie.Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit[J].European Journal of Pharmacology.2010(1)
  • 4Alexander P. Bryant,Robert W. Busby,Wilmin P. Bartolini,Etchell A. Cordero,Gerhard Hannig,Marco M. Kessler,Christine M. Pierce,Robert M. Solinga,Jenny V. Tobin,Shalina Mahajan-Miklos,Mitchell B. Cohen,Caroline B. Kurtz,Mark G. Currie.Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract[J].Life Sciences.2010(19)
  • 5William D. Chey,Anthony J. Lembo,Bernard J. Lavins.Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety[].AMERICAN JOURNAL OF GASTROENTEROLOGY.2012
  • 6Terri M. Wensel,David R. Luthin.Linaclotide: A Novel Approach to the Treatment of Irritable Bowel Syndrome[].Annals of Pharmacotherapy.2011
  • 7B. E. Lacy,J. M. Levenick,M. D. Crowell.LINACLOTIDE IN THE MANAGEMENT OF GASTROINTESTINAL TRACT DISORDERS[].Drugs of Today.2012
  • 8Busby Robert W,Kessler Marco M,Bartolini Wilmin P,Bryant Alexander P,Hannig Gerhard,Higgins Carolyn S,Solinga Robert M,Tobin Jenny V,Wakefield James D,Kurtz Caroline B,Currie Mark G.Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic Peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation[].The Journal of pharmacology and experimental therapeutics.2012
  • 9Lembo Anthony J,Schneier Harvey A,Shiff Steven J,Kurtz Caroline B,MacDougall James E,Jia Xinwei D,Shao James Z,Lavins Bernard J,Currie Mark G,Fitch Donald A,Jeglinski Brenda I,Eng Paul,Fox Susan M,Johnston Jeffrey M.Two randomized trials of linaclotide for chronic constipation[].The New England Quarterly.2011
  • 10Rao Satish,Lembo Anthony J,Shiff Steven J,Lavins Bernard J,Currie Mark G,Jia Xinwei D,Shi Kelvin,MacDougall James E,Shao James Z,Eng Paul,Fox Susan M,Schneier Harvey A,Kurtz Caroline B,Johnston Jeffrey M.A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation[].The American journal of Gastroenterology.2012

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部